Evidence for arylamine N-acetyltransferase activity in Klebsiella pneumoniae

Journal of Microbiology, Immunology and Infection

Volumn 37, Issue 4, 2004, Pages 208-215

  Hui, Chung Sang ^a   Kuo, Hsiu Maan ^b   Yu, Chun Su ^b   Li, Te Mao ^b  

^a JEN AI HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 aminofluorene; 4 aminobenzoic acid; Klebsiella pneumoniae; mRNA; N acetyltransferase

Indexed keywords

2 FLUORENYLAMINE; 4 AMINOBENZOIC ACID; ACETYL COENZYME A; ARYLAMINE ACETYLTRANSFERASE; BACTERIAL ENZYME; COPPER; DIVALENT CATION; ENZYME INHIBITOR; IODOACETAMIDE; ZINC;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; BACTERIUM ISOLATE; CYTOSOL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KLEBSIELLA PNEUMONIAE; MICHAELIS CONSTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAMETER; PH; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TEMPERATURE DEPENDENCE;

4-AMINOBENZOIC ACID; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; DNA, BACTERIAL; FLUORENES; HYDROGEN-ION CONCENTRATION; IODOACETAMIDE; KINETICS; KLEBSIELLA PNEUMONIAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, MESSENGER; SALTS; SUBSTRATE SPECIFICITY; TEMPERATURE;

EID: 4644294234     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Dybing E, Huitfield MS. Species differences in carcinogen metabolism and interspecies extrapolation. IARC Scientific Publication 1992;116:501-22.
2. Holme JA, Trygg B, Sederlund E. Species differences in the metabolism of 2-acetylaminofluorene by hepatocytes in primary monolayer culture. Cancer Res 1986;46:1627-32.
3. Langenbach R, Rudo K, Ellis S, Hir C, Nesnow S. Species variation in bladder cell and liver cell activation of acetylaminofluorene. Cell Biol Toxicol 1987;3:303-17.
4. Miller EC, Miller JA. Searches for the ultimate chemical carcinogens and their reaction with cellular macromolecules. Cancer 1981;47:2327-45.
5. Weber WW, Hein DW. N-acetylation pharmacogenetics. Pharmacol Rev 1985;37:25-79.
6. Weber WW. The acetylator genes and drug response. New York: Oxford University Press; 1987.
7. Hein DW, Ruston TD, Ferguson RT, Doll MA, Gray K. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferase. Arch Toxicol 1994;68:129-33.
8. Cartwright RA, Glasham RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, et al. The role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 1982;2:842-6.
9. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flammang JJ, Kadlubar FF. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 1987;121:1259-61.
10. Ilett KK, David BM, Detchon P, Castledon WM, Kwa A. Acetylator phenotype in colorectal carcinoma. Cancer Res 1987;47:1466-9.
11. Tannen RH, Weber WW. Inheritance of acetylator phenotype in mice. J Pharm Exp Ther 1980;213:480-4.
12. Hein DW, Omichinski JG, Brewer JA, Weber WW. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J Pharmacol Exp Ther 1982;220:8-15.
13. Hein DW, Smolen TN, Fox RR, Weber WW. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains. J Pharmacol Exp Ther 1982;223:40-4.
14. Andres HH, Kolb HJ, Weiss L. Purification and physical-chemical properties of acetyl-CoA: arylamine N-acetyltransferase from pigeon liver. Biochim Biophys Acta 1983;746:182-92.
15. Ho CC, Lin TH, Lai YS, Chung JG, Levy GN, Weber WW. Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. Drug Metab Dispos 1996;24:137-41.
16. Dewhurst SA, Croker SG, Ikeda K, McCaman RE. Metabolism of biogenic amines in Drosophila nervous tissue. Comp Biochem Physiol 1972;43B:975-81.
17. Whitaker DP, Goosey MW. Purification and properties of the enzyme arylamine N-acetyltransferase from the housfly Musca domestica. Biochem J 1993;295:149-54.
18. Chung JG, Kuo HM, Lin TH, Ho CC, Lee JH, Lai JM, et al. Evidence for arylamine N-acetyltransferase in the nematode Anisakis simplex. Cancer Lett 1996;106:1-8.
19. Ho CC, Lin TH. Lai YS, Chung JG, Levy GN, Weber WW. Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. Drug Metab Dispos 1997;24:137-41.
20. 69 residue in the catalytic mechanism of N-hydroxylamine O-acetyltransferase of Salmonella typhimurium: Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms. J Biol Chem 1992;267:8429-36.
21. Chung JG, Wang HH, Tsou MF, Hsieh SE, Lo HH, Yen YS, et al. Evidence for arylamine N-acetyltransferase in the bacteria Helicobacter pylori. Toxicol Lett 1997;91:63-71.
22. Chang FC, Chung JG. Evidence for arylamine N-acetyltransferase activity in the Escherichia coli. Curr Microbiol 1998;36:125-30.
23. Hsieh SE, Lo HH, Yen YS, Chung JG. The effect of vitamin C on N-acetyltransferase activity in Klebsieulla pneumoniae. Food Chem Toxicol 1997;35:1151-7.
24. Chung JG, Tan TW, Tsai HY, Hsieh WT, Chen GW, Lai JM. Effects of aspirin on arylamine N-acetyltransferase activity in Klebsiella pneumoniae. Drug Chem Toxicol 1998;21:507-20.
25. Chen GW, Chung JG, Ho HC, Lin JG. Effects of the garlic compounds diallyl sulphide and diallyl disulphide on arylamine N-acetyltransferase activity in Klebsiella pneumoniae. J Appl Toxicol 1999;19:75-81.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
27. Cleland, WW. The statistical analysis of enzyme kinetics data. Adv Enzymol Relat Areas Mol Biol 1967;29:1-14.
28. Chung JG, Levy GN, Weber WW. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice. Drug Metab Dispos 1993;21:1057-63.
29. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization and functional expression. DNA Cell Biol 1990;9:193-203.
30. Ebisawa T, Deguchi T. Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferase. Biochem Biophys Res Commun 1991;177:1252-7.
31. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984;12:1687-96.
32. Yamada R, Bradshaw RA. Rat liver polysome N-acetyltransferase: Isolation and characterization. Biochemistry 1991;30:1010-6.
33. Einisto P, Watanabe M, Ishidate M, Nohmi T. Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutat Res 1991;259:95-102.
34. Andres HH, Vogel RS, Tarr GE, Johnson L, Weber WW. Purification, physicochemical and kinetic properties of liver acetyl-CoA:arylamine N-acetyltransferase from rapid acetylator rabbits. Mol Pharmacol 1987;31:446-56.
35. Mattano SS, Land S, King CM, Weber WW. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase. Mol Pharmacol 1989;35:599-609.
36. Deguchi T, Sakamoto Y, Sasaki Y, Uyemura K. Arylamine N-acetyltransferase from chicken liver. I. Monoclonal antibodies immunoaffinity purification and amino acid sequence. J Biol Chem 1988;263:7528-33.
37. Whitaker DP, Goosey MW. Purification and properties of the enzyme arylamine N-acetyltransferase from the housfly Musca domestica. Biochem J 1993;295:149-54.